Announcement on Voluntary Disclosure of FDA Approval for the Clinical Trial Application for 6MW5311 Injection

About this update from Mabwell (shanghai) Bioscience Co., Ltd. Class A

Announcement on Voluntary Disclosure of FDA Approval for the Clinical Trial Application for 6MW5311 Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Mabwell (shanghai) Bioscience Co., Ltd. Class A